A phase I study of BPX-201 vaccine plus AP1903 for chemo-naive metastatic castrate-resistant prostate cancer (mCRPC).
Guru Sonpavde
Research Funding - Bellicum Pharmaceuticals
Thomas E. Hutson
Research Funding - Bellicum Pharmaceuticals
Graeme Bolger
Research Funding - Bellicum Pharmaceuticals
Lawrence Fong
No relevant relationships to disclose
Eric Jay Small
No relevant relationships to disclose
David M. Spencer
Employment or Leadership Position - Bellicum Pharmaceuticals
Stock Ownership - Bellicum Pharmaceuticals
Annemarie Moseley
Employment or Leadership Position - Bellicum Pharmaceuticals
Stock Ownership - Bellicum Pharmaceuticals
Kevin Mark Slawin
Employment or Leadership Position - Bellicum Pharmaceuticals
Consultant or Advisory Role - Bellicum Pharmaceuticals
Stock Ownership - Bellicum Pharmaceuticals